Skip to main content

Home Library Publishing About

Home Library Publishing About

Lowell Zeta

ID:LEX-AR-CPYJP50W

/

Unclaimed

/

Organization: Hogan Lovells

FDA and EMA Address Quality and Manufacturing Challenges for Breakthrough Therapies Undergoing Expedited Approval

Focus on Regulation · August 5, 2019

FDA introduces new standardized inspection protocols for sterile drug manufacturers to modernize and strengthen oversight

Focus on Regulation · November 15, 2018

FTC takes on deceptive stem cell therapy claims for blindness cure and autism treatment

Focus on Regulation · November 7, 2018

FDA publishes internal policy on prioritizing surveillance inspections for drug manufacturing sites

Focus on Regulation · September 5, 2018

FDA Shows that it Means Business in Stopping Stem Cell Clinics that Put Patients at Risk

Focus on Regulation · May 11, 2018

Previous

12 3

Next

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Copyright © 2026 LexBlog, Inc. and The Library at LexBlog, Inc. All Rights Reserved.

Privacy Policy Terms of Service